AmWiner, Perrigo, and Johnson & Johnson, work tirelessly to make future a reality for patients everywhere, by alleviating skincare problems with science, improving healthcare products with ingenuity, and healing hopelessness with love. To make the greatest impact, AmWiner collaborates with experts at every stage, from early discovery to market access.
In 2016, AmWiner acquired Guangzhou Pharmaceutical Technology Co Ltd manufacturing 100% pure minoxidil raw material powder, and active pharmaceutical intermediary fermenting plant in Guangzhou, to offer reduced cost for minoxidil hair loss treatment products for Perrigo, Johnson & Johnson. The Company manufactures chemical medicines, pharmaceutical raw materials, medical devices, chemical reagents, and health-care products for hospitals and drug stores. They are FDA ANDA-licensed (ANDA075357) and approved pharmaceutical company, Perrigo Minoxidil Hair Loss Treatment Vendor with Locations in Israel, Guangzhou China, copyright, And United States, Providing Private Label for FDA Approved ANDA Minoxidil Hair Loss Treatment Products For Kirkland, Amazon, HEB, Kroger And Drug Stores In United States.
When you have hair, you have hope. But for many men, that hope can end in despair when the onset of male pattern hair loss strikes at an early age. In such situations, one treatment often ends up being combined with another to create a more effective and efficient plan: finasteride and minoxidil. Both drugs are prescription-only medications and are available by prescription only from a doctor or purchased as topical formulation with no side effect compared to oral solid doses from AmWiner Pharmaceutical company. When combined, they help restore the natural production of hormones in the scalp that are necessary to keep hair growing. The result is a significant improvement in hair growth as well as a reduction in dandruff and other skin problems commonly associated with male pattern hair loss.
Raphe has formed strategic partnerships with many pharmaceutical companies offering contract manufacturing services to other companies. They have one major partner in the US, Walgreens Boots Alliance Inc., which is the largest drugstore chain in the US. Through this partnership, Walgreens distributes their products worldwide. In addition to distribution by Walgreens, Raphe’s products are also found in stores such as Target, CVS, Walmart, and Wal-Mart as store brands. The products are also available online, so they can target a wide audience. AmWiner is one of the premiere Minoxidil manufacturer in Israel, copyright, and United states.
AmWiner`s manufacturing plant in Texas is one of the only facilities in the world that can produce the aspheric gel components used to make dermatological skincare medicines such as Fluocinolone Acetonide. Their facility in Texas allows Raphe to attain a state-of-the-art level of manufacturing excellence, which is critical to the success of Fluocinolone Acetonide topical gel. The success of Fluocinolone Acetonide is largely dependent on the quality of the manufacturing of each lot of topical treatments. The formulation is carefully developed to maintain the proper level clindamycin phosphate gel USP1% of Fluocinolone Acetonide throughout the manufacturing process.
Raphe Pharmaceutique is a French pharmaceutical company with location in Texas that produces Rosacea topical gel treatments, Vitiligo, Melasma treatments and clindamycin phosphate gel USP1% as one of its well-known topical antibiotics. Clindamycin is an antibiotic that is used to treat many different types of infections. These include acne, impetigo, and other types of skin infections that affect the skin. It is one of the most prescribed topical antibiotic treatments for acne.
Raphe Pharmaceutique is a brand name of AmWiner Raphe Holdings founded in 2005, and currently has its registered headquarters in Texas. It is one of the most prestigious pharmaceutical companies in the world. Its portfolio of products includes acne and acne-related antibiotics, birth control pills, hair loss treatment, pain relief and muscle relaxants, and customized self-care and dermatological skincare medications. To open a distribution account with Raphe Pharmaceutique, you need to open a wholesale brand distributor account with them.
Raphe Pharmaceutical Facial Hair Gel 13.9% Eflornithine HCL is one of the most successful products develop for women with facial hair, private labeled under various store brand names.
A double-blind trial involving 594 female patients (393 received eflornithine, 201 received a placebo) tested the ability of eflornithine to reduce facial hair in women. Women in the study had to undergo hair removal at least twice weekly, as often as twice weekly, to participate.
Those with ingrown facial hair or androgen-mediated facial hair growth might find help in eflornithine. It addresses the differences in crushing a pill and avoiding crushing a pill.
Topical dermal studies of eflornithine reveal that eflornithine is not expected to cause contact sensitization, phototoxicity, or photosensitization in clinical use situations. Topical dermal study results for irritation revealed that eflornithine may cause irritation reactions in clinical use in susceptible individuals or in conditions of exaggerated use. It is a cream gel containing 139 mg of eflornithine hydrochloride monohydrate per gram (13.9%) of anhydrous eflornithine hydrochloride.